Last but certainly not least, we get to hear from Bhaumik A. Pandya, one of our talented chemists. What is Bhau grateful for? He says his family, friends, and science that helps patients. We could not agree more, Bhau!?
Vigil Neuroscience
生物技术研究
Watertown,MA 8,647 位关注者
Harnessing the power of microglia to transform treatments for neurodegenerative diseases
关于我们
Vigil Neuroscience is a clinical-stage biotechnology company focused on developing treatments for both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. We are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities in our efforts to develop precision-based therapies to improve the lives of patients and their families. VGL101, our lead clinical candidate, is a fully human monoclonal antibody agonist targeting human triggering receptor expressed on myeloid cells 2 (TREM2) in people with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare and fatal neurodegenerative disease. We are also developing VG-3927, a novel small molecule TREM2 agonist, to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer’s disease (AD) in genetically defined subpopulations.
- 网站
-
https://www.vigilneuro.com
Vigil Neuroscience的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Watertown,MA
- 类型
- 上市公司
- 创立
- 2020
- 领域
- neuroscience和microglia
地点
-
主要
100 Forge Rd
Suite 700
US,MA,Watertown,02472
Vigil Neuroscience员工
动态
-
Coming up on her one year anniversary with Vigil, we’re lucky to have Sweta Chalise in our Quality Department. When asked, Sweta shared that she is grateful to have her family around her. We’re glad to have YOU around, Sweta!? #VigilantForYou #LifeAtVigil
-
Over in our IT Department, Eric Brophy is always busy keeping us connected and secure. This year, Eric is thankful for good medicine – a sentiment we wholeheartedly share. Thanks Eric! #VigilantForYou #LifeAtVigil
-
Meet Rachel Utama, who joins us from Northeastern University, where she is studying Data Science and Behavioral Neuroscience. We’re grateful for awesome co-ops like you, Rachel! #LifeAtVigil
-
In the spirit of Thanksgiving, we came together for our second annual Vigil team potluck! Our talented team brought in 26 dishes to create a festive buffet filled with delicious eats from different countries and cultures. #LifeAtVigil
-
"Cultivate the habit of being grateful for every good thing that comes to you, and to give thanks continuously." – Ralph Waldo Emerson Over the next few days leading up to Thanksgiving, we’ll be introducing some members of the Vigil team and sharing what they’re grateful for. Starting off with our Assistant Controller, Jennifer Muccio, MSA, MBA - thank you for sharing, Jenny! #VigilantForYou #LifeAtVigil
-
Did you know that increased levels of #TREM2 are associated with slower progression of Alzheimer’s Disease? Using TREM2 to activate microglia could allow us to use the brain’s own immune system to fight neurodegeneration. Learn more about our approach:?https://lnkd.in/gPSATNEh #VigilantForYou #AlzheimersAwarenessMonth #Microglia
-
Sometimes the smallest signals in our body can lead to the biggest breakthroughs. As a result of our ongoing partnership with the ALSP Community, we recently shared a blog post on the importance of biomarkers in rare disease research and drug development. We are so grateful to the patients and care partners involved in ILLUMINATE, the first-ever ALSP natural history study, as it has helped us turn biomarker clues into hope for future treatments. We would also like to extend a special thanks to Global Genes for providing a platform for us to share. You can read the full article here: https://lnkd.in/e8Tayn7s #Biomarkers #Microglia #Neuroscience #VigilantForYou
-
$VIGL News: Management participated in a fireside chat at the Jefferies London Healthcare Conference earlier this morning.?Watch the webcast here:?https://lnkd.in/gPSATNEh
-
$VIGL News: Management will participate in a fireside chat at the Stifel 2024 Healthcare Conference later this afternoon.?Watch the webcast here: https://lnkd.in/gPSATNEh